Drug intelligence / Profile preview

Col-immune

Development stage: Preclinical
Lead developer: Epione Pharmaceuticals
Modality: Recombinant Proteins and Enzymes
Administration: Oral

Overview

Col-immune is a nutraceutical supplement developed by Epione Pharmaceuticals, appearing in their product pipeline as an immune-support agent. The product is formulated using bovine colostrum, a nutrient-rich substance produced by cows shortly after giving birth. Bovine colostrum is naturally high in immunoglobulins (particularly IgG), lactoferrin, and various growth factors, which are intended to provide passive immunity and support the body's natural defense systems. Additionally, it is often used to promote gastrointestinal health by maintaining the integrity of the gut lining. As a nutraceutical, Col-immune is positioned for consumer health and wellness rather than as a primary treatment for specific medical conditions.

Brand names: Col-immune
Other names: bovine colostrum supplement

Beyond the preview

Go deeper on Col-immune.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Col-immune.

Explore the full profile